vs
IMAX（IMAX）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
Tarsus Pharmaceuticals, Inc.的季度营收约是IMAX的1.2倍（$151.7M vs $125.2M），IMAX净利率更高（0.5% vs -5.5%，领先6.0%），Tarsus Pharmaceuticals, Inc.同比增速更快（128.4% vs 35.1%），IMAX自由现金流更多（$28.0M vs $13.0M），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 25.8%）
IMAX公司是加拿大的影视放映技术企业，1967年创立于蒙特利尔，总部位于多伦多地区，在纽约、洛杉矶均设有业务点。核心业务包括IMAX摄影机与放映系统的设计制造，同时面向全球合作影院提供影片开发、制作、后期及发行服务，是沉浸式观影技术领域的领先企业。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
IMAX vs TARS — 直观对比
营收规模更大
TARS
是对方的1.2倍
$125.2M
营收增速更快
TARS
高出93.3%
35.1%
净利率更高
IMAX
高出6.0%
-5.5%
自由现金流更多
IMAX
多$15.0M
$13.0M
两年增速更快
TARS
近两年复合增速
25.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $125.2M | $151.7M |
| 净利润 | $637.0K | $-8.4M |
| 毛利率 | 57.6% | — |
| 营业利润率 | 19.3% | -5.3% |
| 净利率 | 0.5% | -5.5% |
| 营收同比 | 35.1% | 128.4% |
| 净利润同比 | -88.0% | 63.8% |
| 每股收益（稀释后） | $0.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMAXTARS
| Q4 25 | $125.2M | $151.7M | ||
| Q3 25 | $106.7M | $118.7M | ||
| Q2 25 | $91.7M | $102.7M | ||
| Q1 25 | $86.7M | $78.3M | ||
| Q4 24 | $92.7M | $66.4M | ||
| Q3 24 | $91.5M | $48.1M | ||
| Q2 24 | $89.0M | $40.8M | ||
| Q1 24 | $79.1M | $27.6M |
净利润IMAXTARS
| Q4 25 | $637.0K | $-8.4M | ||
| Q3 25 | $20.7M | $-12.6M | ||
| Q2 25 | $11.3M | $-20.3M | ||
| Q1 25 | $2.3M | $-25.1M | ||
| Q4 24 | $5.3M | $-23.1M | ||
| Q3 24 | $13.9M | $-23.4M | ||
| Q2 24 | $3.6M | $-33.3M | ||
| Q1 24 | $3.3M | $-35.7M |
毛利率IMAXTARS
| Q4 25 | 57.6% | — | ||
| Q3 25 | 63.1% | — | ||
| Q2 25 | 58.5% | — | ||
| Q1 25 | 61.4% | — | ||
| Q4 24 | 52.2% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 49.4% | — | ||
| Q1 24 | 59.3% | — |
营业利润率IMAXTARS
| Q4 25 | 19.3% | -5.3% | ||
| Q3 25 | 27.2% | -12.2% | ||
| Q2 25 | 15.6% | -21.6% | ||
| Q1 25 | 19.3% | -33.5% | ||
| Q4 24 | 10.3% | -36.8% | ||
| Q3 24 | 21.2% | -52.3% | ||
| Q2 24 | 3.2% | -81.6% | ||
| Q1 24 | 15.3% | -136.5% |
净利率IMAXTARS
| Q4 25 | 0.5% | -5.5% | ||
| Q3 25 | 19.4% | -10.6% | ||
| Q2 25 | 12.3% | -19.8% | ||
| Q1 25 | 2.7% | -32.1% | ||
| Q4 24 | 5.7% | -34.8% | ||
| Q3 24 | 15.2% | -48.7% | ||
| Q2 24 | 4.0% | -81.6% | ||
| Q1 24 | 4.1% | -129.4% |
每股收益（稀释后）IMAXTARS
| Q4 25 | $0.02 | $-0.17 | ||
| Q3 25 | $0.37 | $-0.30 | ||
| Q2 25 | $0.20 | $-0.48 | ||
| Q1 25 | $0.04 | $-0.64 | ||
| Q4 24 | $0.09 | $-0.57 | ||
| Q3 24 | $0.26 | $-0.61 | ||
| Q2 24 | $0.07 | $-0.88 | ||
| Q1 24 | $0.06 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.2M | $417.3M |
| 总债务越低越好 | — | $72.4M |
| 股东权益账面价值 | $337.9M | $343.4M |
| 总资产 | $894.0M | $562.2M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资IMAXTARS
| Q4 25 | $151.2M | $417.3M | ||
| Q3 25 | $143.1M | $401.8M | ||
| Q2 25 | $109.3M | $381.1M | ||
| Q1 25 | $97.1M | $407.9M | ||
| Q4 24 | $100.6M | $291.4M | ||
| Q3 24 | $104.5M | $317.0M | ||
| Q2 24 | $91.6M | $323.6M | ||
| Q1 24 | $81.0M | $298.5M |
总债务IMAXTARS
| Q4 25 | — | $72.4M | ||
| Q3 25 | — | $72.3M | ||
| Q2 25 | — | $72.1M | ||
| Q1 25 | — | $72.0M | ||
| Q4 24 | — | $71.8M | ||
| Q3 24 | — | $71.7M | ||
| Q2 24 | — | $71.6M | ||
| Q1 24 | — | $29.9M |
股东权益IMAXTARS
| Q4 25 | $337.9M | $343.4M | ||
| Q3 25 | $349.5M | $335.1M | ||
| Q2 25 | $320.4M | $332.6M | ||
| Q1 25 | $299.5M | $342.5M | ||
| Q4 24 | $299.5M | $224.5M | ||
| Q3 24 | $289.4M | $237.5M | ||
| Q2 24 | $267.2M | $252.2M | ||
| Q1 24 | $258.8M | $275.2M |
总资产IMAXTARS
| Q4 25 | $894.0M | $562.2M | ||
| Q3 25 | $889.6M | $534.6M | ||
| Q2 25 | $868.6M | $495.0M | ||
| Q1 25 | $848.3M | $500.8M | ||
| Q4 24 | $830.4M | $377.0M | ||
| Q3 24 | $847.6M | $376.3M | ||
| Q2 24 | $827.4M | $376.8M | ||
| Q1 24 | $824.1M | $349.3M |
负债/权益比IMAXTARS
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.30× | ||
| Q2 24 | — | 0.28× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.4M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $28.0M | $13.0M |
| 自由现金流率自由现金流/营收 | 22.3% | 8.6% |
| 资本支出强度资本支出/营收 | 1.1% | 4.2% |
| 现金转化率经营现金流/净利润 | 46.11× | — |
| 过去12个月自由现金流最近4个季度 | $118.9M | $-22.3M |
8季度趋势，按日历期对齐
经营现金流IMAXTARS
| Q4 25 | $29.4M | $19.3M | ||
| Q3 25 | $67.5M | $18.3M | ||
| Q2 25 | $23.2M | $-29.4M | ||
| Q1 25 | $7.0M | $-20.7M | ||
| Q4 24 | $11.5M | $-22.2M | ||
| Q3 24 | $35.3M | $-8.7M | ||
| Q2 24 | $35.0M | $-14.4M | ||
| Q1 24 | $-11.0M | $-37.8M |
自由现金流IMAXTARS
| Q4 25 | $28.0M | $13.0M | ||
| Q3 25 | $64.8M | $16.3M | ||
| Q2 25 | $20.9M | $-30.4M | ||
| Q1 25 | $5.3M | $-21.2M | ||
| Q4 24 | $6.9M | $-22.3M | ||
| Q3 24 | $34.2M | $-8.9M | ||
| Q2 24 | $33.5M | $-15.4M | ||
| Q1 24 | $-12.1M | $-38.0M |
自由现金流率IMAXTARS
| Q4 25 | 22.3% | 8.6% | ||
| Q3 25 | 60.7% | 13.8% | ||
| Q2 25 | 22.8% | -29.6% | ||
| Q1 25 | 6.1% | -27.1% | ||
| Q4 24 | 7.4% | -33.5% | ||
| Q3 24 | 37.3% | -18.6% | ||
| Q2 24 | 37.6% | -37.8% | ||
| Q1 24 | -15.3% | -137.5% |
资本支出强度IMAXTARS
| Q4 25 | 1.1% | 4.2% | ||
| Q3 25 | 2.6% | 1.6% | ||
| Q2 25 | 2.6% | 1.0% | ||
| Q1 25 | 1.9% | 0.8% | ||
| Q4 24 | 5.0% | 0.1% | ||
| Q3 24 | 1.2% | 0.6% | ||
| Q2 24 | 1.8% | 2.5% | ||
| Q1 24 | 1.4% | 0.6% |
现金转化率IMAXTARS
| Q4 25 | 46.11× | — | ||
| Q3 25 | 3.27× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 2.99× | — | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 9.78× | — | ||
| Q1 24 | -3.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
TARS
暂无分部数据
